Bevnacept 400mg Injection: Effective Medication for Your Treatment

Bevnexxa 400mg Injection

Description:

• Bevnexxa 400mg Injection is an anticancer medicine containing the active ingredient Bevacizumab.
• It is used to prevent tumour growth and is indicated alongside other chemotherapy drugs to treat various types of cancer.

Uses:

• Metastatic breast cancer
• Brain cancer (glioblastoma multiforme)
• Cervical cancer
• Kidney cancer
• Lung cancer
• Colorectal cancer
• Ovarian cancer
• Fallopian tube cancer
• Primary peritoneal cancer

Administration:

• Administered intravenously as an infusion.
• The infusion should be given immediately after dilution.

Important Safety Information:

• Not recommended for adolescents and children under 18.
• Use effective birth control during treatment and for at least six months after the last dose.
• Discuss fertility preservation with your doctor if planning for pregnancy.
• Avoid breastfeeding during and after treatment.
• Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take.

Storage:

• Store at 2˚C to 8˚C. Do not freeze or shake.
• Protect from light.
• Keep out of reach of children.

Side Effects:

• Serious: headache, vision changes, confusion, severe allergic reactions, high blood pressure, delayed wound healing following surgery, protein in urine, severe infections, blood clots, gut perforation, nosebleeds, heart problems, mouth sores, shortness of breath.
• Common: numbness in hands or feet, weakness, diarrhoea, nausea, vomiting, abdominal pain, constipation, loss of appetite, weight loss, changes in taste and speech, fever, dry skin, back pain.

Warnings:

• Inform your doctor if you have high blood pressure, high blood sugar, stomach disorders, or heart problems.
• Do not take the medicine for 28 days before and after surgery.
• Report any dental issues that require surgery before taking this medicine.
• Report visual changes or confusion to your doctor.

FAQs:

1. Is Bevnexxa 400mg Injection used as standalone treatment in cancers?

   • Bevnexxa 400mg Injection can be used as monotherapy or in combination with chemotherapy or immunotherapy medications.

2. Is it safe for women to use Bevnexxa 400mg Injection?

   • Women with reproductive potential should discuss effective birth control methods with their doctor during and after treatment.

3. Is it safe to undergo surgery during the treatment with Bevnexxa 400mg Injection?

   • Avoid surgery within 28 days before or after treatment due to the risk of bleeding and poor wound healing.

4. Do the side effects of Bevnexxa 400mg Injection last for a chronic period?

   • Side effects occur until the drug concentration stays in the body, which is approximately 4 months after the final dose.

5. How is Bevnexxa 400mg Injection administered?

   • Administered intravenously through infusion, with the amount based on the patient’s body weight, height, and age. The first dose is administered for 90 minutes, and if well tolerated, the infusion time can be reduced to 30 minutes.

6. Can I take Bevnexxa 400mg Injection if I am pregnant?

   • Inform your physician before starting treatment if you are pregnant or planning for pregnancy, as the medicine may cause harm to the unborn baby.

Therapeutic Effects:

• Bevnexxa 400mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy in the treatment of various advanced cancers.
• It binds to the protein vascular endothelial growth factor A (VEGF-A), inhibiting the formation of blood vessels that supply oxygen and nutrients to the tumour, thereby slowing down cancer progression.

Fact Box:

• Molecule name: Bevacizumab
• Therapeutic class: Anticancer
• Pharmacological class: VEGF Inhibitor
• Indications:
  • Glioblastoma multiforme (brain cancer)
  • Persistent, recurrent, or metastatic breast cancer
  • Metastatic cervical cancer
  • Advanced kidney cancer
  • Metastatic colorectal cancer
  • Advanced non-small-cell lung cancer
  • Liver Cancer- Hepatocellular carcinoma
  • Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer

Tags: Bevnacept, Injection, 400mg, Medication, Pharmaceutical, Healthcare, Drug, Treatment, Medicine, MedicalProduct